COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30
23/04/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, April 23, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTCQB: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ( [...]
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
23/04/2019
Treatment with Nomacopan (Coversin) in three patients with mild-to-moderate bullous pemphigoid resulted in no drug-related adverse events and rapid reduction in Bullous Pemphigoid Disease Area Index (BPDAI) global score [...]
ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation
23/04/2019
MONTREAL, April 23, 2019 (GLOBE NEWSWIRE) -- ExCellThera Inc., an advanced clinical stage biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, [...]
Japan Cell Therapy Transaction Yields $3MM
23/04/2019
Strategic focus on building a leading oncology company; Two transactions this month yielding $7MM SAN DIEGO, April 23, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today [...]
Entasis Therapeutics Strengthens Leadership Team with Appointment of Eric Kimble as Chief Commercial Officer
23/04/2019
Kimble to lead global commercialization strategy for the Company’s late-stage antimicrobial pipeline WALTHAM, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage [...]
Nemaura Announces Successful Completion of Summative Human Factors Usability Study for SugarBEAT®
23/04/2019
Final step required prior to filing de novo application to the U.S. Food and Drug Administration Loughborough, England , April 23, 2019 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology [...]
OmniSeq and LabCorp Extend Exclusive Distribution Pact and Complete Follow-On Investment Agreement
23/04/2019
Funding Will Support OmniSeq’s Pursuit of Single-Site PMA FDA Approval for Advanced Next Generation Sequencing Oncology Panels BUFFALO, N.Y., April 23, 2019 (GLOBE NEWSWIRE) -- OmniSeq ® , a CAP-accredited, molecular [...]
Profound Medical to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Progressive Care Inc. Announces March Sales and Issues Acquisition Update
23/04/2019
MIAMI, April 23, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
Medexus CEO to Present at Two Upcoming Investor Conferences
23/04/2019
MONTREAL, April 23, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) announces that Ken d’Entremont, Chief Executive Officer, has been invited to present and [...]
Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan
23/04/2019
EAST RUTHERFORD, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
CareDx to Announce First Quarter 2019 Financial Results on May 8th, 2019
23/04/2019
BRISBANE, Calif., April 23, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on creating diagnostic solutions for organ transplant patients, today announced that it [...]
Genocea to Host Quarterly Corporate Update Conference Call & Webcast on April 30th at 9:00 am ET
23/04/2019
CAMBRIDGE, Mass., April 23, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, will host its first-quarter 2019 financial [...]
IntelGenx to Promote Oral Films CDMO Services at CPhI North America
23/04/2019
SAINT LAURENT, Quebec, April 23, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it will promote its contract development and [...]
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual Meeting
23/04/2019
BOTHELL, Wash., April 23, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Blissco Submits Application for Cannabis Oil Sales Licence
23/04/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, April 23, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
Eve & Co to Report Financial Results for the Two and Fourteen Month Periods ended December 31, 2018 on April 30, 2019
23/04/2019
TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce it will report financial results for the two and fourteen month [...]
Pluristem Therapeutics Issues Shareholder Update
23/04/2019
Recent financing provides funding through multiple potentially value-creating milestones Providing short and mid-term milestones, targeting marketing and significant contracts HAIFA, Israel, April 23, 2019 (GLOBE [...]
VBI Vaccines Provides Update on GBM Program and Announces Upcoming Conference Call
23/04/2019
10mcg dose selected to advance into Part B of Phase 1/2a study of VBI-1901 in recurrent GBM Expanded data from Part A of the Phase 1/2a study of VBI-1901 selected for poster presentation at ASCO Conference call and [...]

Pages